期刊文献+

反相高效液相色谱法测定血清中阿立哌唑及其代谢物 被引量:1

RP-HPLC Determination of Aripiprazole and its Metabolite in Blood Serum
下载PDF
导出
摘要 采用反相高效液相色谱法对血清中阿立哌唑及其代谢物脱氢阿立哌唑进行测定。血清样品经乙醚提取,所得提取液再经35℃氮气吹干,残留物经流动相溶解后,用Zorbax-C18色谱柱分离,用紫外检测器于254 nm波长处测定。阿立哌唑及其代谢物脱氢阿立哌唑的线性范围分别为4.0~2 000μg.L-1和4.0~1 500μg.L-1;测定下限(10S/N)均为4.0μg.L-1。相对回收率分别为100.3%~102.7%和93.7%~103.9%;日内和日间相对标准偏差(n=5)均小于7%。 A method of RP-HPLC for determination of aripiprazole and its metabolite,dehydro-aripiprazole was proposed.Sample of blood serum was extracted with ethyl ether and the eluate obtained was evaporated to dryness by N2-blowing at 35 ℃.The residue was dissolved with the mobile phase mixture and separated by passing through Zorbax-C18 column,and the eluate from the column was used for HPLC analysis with UV detector at the wavelength of 254 nm.Linearity ranges of aripiprazole and dehydro-aripiprazole were kept from 4.0 to 2 000 μg·L-1 and 4.0 to 1 500 μg·L-1 respectively,with same lower limits of determination(10S/N) of 4.0 μg·L-1.Values of relative recovery of aripiprazole and dehydro-aripiprazole in the range of 100.3%-102.7% and 93.7%-103.9% were found respectively.Values of intraday and interday relative standard deviation(n=5) were all less than 7%.
出处 《理化检验(化学分册)》 CAS CSCD 北大核心 2010年第11期1293-1295,1299,共4页 Physical Testing and Chemical Analysis(Part B:Chemical Analysis)
基金 国家重点基础研究发展计划(2007CB512306)
关键词 反相高效液相色谱法 阿立哌唑 脱氢阿立哌唑 血清 RP-HPLC Aripiprazole Dehydro-aripiprazole Blood serum
  • 相关文献

参考文献1

二级参考文献5

  • 1Burris KD,Molski TF,Xu C,et al.Aripiprazole,a novel antipsychotic,is a high-affinity partial agonist at human dopamine D2 receptors.J Pharmacol Exp Ther,2002,302(3):381~389.
  • 2Kane JM,Carson WH,Saha AR,et al.Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.J Clin Psychiatry,2002,63 (5):763~771.
  • 3Saha AR,Carson WH,AH MW,et al.Efficacy and safety of aripiprazole and risperidone vs.placebo in patients with schizophrenia and schizoaffectective disorder.WJ Biol Psychiatry,2001,2 (Suppl 1):305.
  • 4Lieberman J,Carson WH,Saha AR,et al.Meta-analysis of the efficacy of aripiprazole in schizophrenia.Int J Neuropsychopharmacol,2002,5(Suppl 1):186.
  • 5Petrel JL,Saha AR Mcecoy JP.Aripiprazole,a new atypical antipsychotic:overview of phase results poster.Presented at the 36th annual meeting of the American College of Neuropsychopharmacology,Walkloa,Hawaii,1997.8~12.

共引文献4

同被引文献1

  • 1Hiemke C,Baumann P,Bergemann N,Conca A,Dietmaier O,Egberts K,Fric M,Gerlach M,Greiner C,Gründer G,Haen E,Havemann-Reinecke U,Jaquenoud Sirot E,Kirchherr H,Laux G,Lutz UC,Messer T,Müller MJ,Pfuhlmann B,Rambeck B,Riederer P,Schoppek B,Stingl J,Uhr M,Ulrich S,Waschgler R,Zernig G,李文标(译),果伟(译),阮灿军(译),贺静(译),汤宜朗(审校),王传跃(审校).AGNP精神科治疗药物监测共识指南:2011[J].实用药物与临床,2016,19(10):1193-1218. 被引量:40

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部